Finepoint Capital LP Diversified Active

Location: Boston, MA

CIK: 0001608126 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 13, 2024

Total Value: $317M (100.0% shares, 0.0% debt)

Holdings (27)

CYTK CYTOKINETICS INC 11.4%

Value $36.04M Shares 431,693 Est. Cost $39.39 Unrealized -8.1%

— SPIRIT AIRLINES INC 8.8%

Value $27.86M Shares 1,700,000 Est. Cost — Unrealized —

ACAD ACADIA PHARMACEUTICALS INC 7.6%

Value $24.1M Shares 769,653 Est. Cost $19.38 Unrealized +23.2%

FOLD AMICUS THERAPEUTICS INC 6.7%

Value $21.13M Shares 1,489,025 Est. Cost $8.83 Unrealized +28.7%

ARVN ARVINAS INC 6.6%

Value $20.77M Shares 504,700 Est. Cost $42.02 Unrealized -44.4%

ASND ASCENDIS PHARMA A/S 6.5%

Value $20.63M Shares 163,772 Est. Cost $96.47 Unrealized —

— SPRINGWORKS THERAPEUTICS INC 6.4%

Value $20.33M Shares 556,928 Est. Cost $27.22 Unrealized —

— HOME PLATE ACQUISITION CORP 6.3%

Value $20.01M Shares 331,416 Est. Cost $0.60 Unrealized —

GLPG GALAPAGOS NV 5.9%

Value $18.64M Shares 458,659 Est. Cost $48.14 Unrealized —

RVMD REVOLUTION MEDICINES INC 5.6%

Value $17.7M Shares 617,100 Est. Cost $27.92 Unrealized -14.0%

LBRDK LIBERTY BROADBAND CORP 4.7%

Value $14.87M Shares 184,460 Est. Cost $78.60 Unrealized 0.0%

RLAY RELAY THERAPEUTICS INC 4.6%

Value $14.51M Shares 1,317,870 Est. Cost $14.33 Unrealized -41.1%

— MORPHIC HOLDING INC 4.5%

Value $14.35M Shares 496,856 Est. Cost $44.89 Unrealized —

SRPT SAREPTA THERAPEUTICS INC 4.4%

Value $14.02M Shares 145,357 Est. Cost $115.73 Unrealized -17.1%

TVTX TRAVERE THERAPEUTICS INC 4.1%

Value $12.9M Shares 1,435,321 Est. Cost $17.56 Unrealized -58.5%

PRTA PROTHENA CORP PLC 4.0%

Value $12.69M Shares 349,300 Est. Cost $33.98 Unrealized +13.3%

SLDB SOLID BIOSCIENCES INC 1.9%

Value $5.902M Shares 961,251 Est. Cost $5.95 Unrealized -46.2%

— CALIDI BIOTHERAPEUTICS INC 0.1%

Value $189K Shares 125,000 Est. Cost $3.33 Unrealized —

— CHURCHILL CAPITAL CORP VII 0.0%

Value $71,295 Shares 548,000 Est. Cost $0.92 Unrealized —

MLTX MOONLAKE IMMUNOTHERAPEUTICS 0.0%

Value $62,740 Shares 895,000 Est. Cost $43.35 Unrealized +18.9%

CNDAW CONCORD ACQUISITION CORP II 0.0%

Value $53,083 Shares 408,333 Est. Cost $0.95 Unrealized —

CLDWW CALIDI BIOTHERAPEUTICS INC 0.0%

Value $32,760 Shares 655,200 Est. Cost $0.50 Unrealized —

— ROSS ACQUISITION CORP II 0.0%

Value $24,621 Shares 439,666 Est. Cost $0.89 Unrealized —

CDAWF COMPASS DIGITAL ACQUISITION CORP 0.0%

Value $22,259 Shares 459,906 Est. Cost $0.76 Unrealized —

— MARBLEGATE ACQUISITION CORP 0.0%

Value $22,050 Shares 735,000 Est. Cost $0.50 Unrealized —

IVCPW SWIFTMERGE ACQUISITION CORP 0.0%

Value $20,090 Shares 490,000 Est. Cost $0.21 Unrealized —

LSBWF YS BIOPHARMA CO LTD 0.0%

Value $13,279 Shares 489,999 Est. Cost $0.16 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CYTK	CYTOKINETICS INC	431,693	$36.04M	11.4%	$39.39	-8.1%	COM NEW	23282W605
—	SPIRIT AIRLINES INC	1,700,000	$27.86M	8.8%	—	—	Call	848577102
ACAD	ACADIA PHARMACEUTICALS INC	769,653	$24.1M	7.6%	$19.38	+23.2%	COM	004225108
FOLD	AMICUS THERAPEUTICS INC	1,489,025	$21.13M	6.7%	$8.83	+28.7%	COM	03152W109
ARVN	ARVINAS INC	504,700	$20.77M	6.6%	$42.02	-44.4%	COM	04335A105
ASND	ASCENDIS PHARMA A/S	163,772	$20.63M	6.5%	$96.47	—	SPONSORED ADR	04351P101
—	SPRINGWORKS THERAPEUTICS INC	556,928	$20.33M	6.4%	$27.22	—	COM	85205L107
—	HOME PLATE ACQUISITION CORP	331,416	$20.01M	6.3%	$0.60	—	*W EXP 09/30/202	43734R111
GLPG	GALAPAGOS NV	458,659	$18.64M	5.9%	$48.14	—	SPON ADR	36315X101
RVMD	REVOLUTION MEDICINES INC	617,100	$17.7M	5.6%	$27.92	-14.0%	COM	76155X100
LBRDK	LIBERTY BROADBAND CORP	184,460	$14.87M	4.7%	$78.60	0.0%	COM SER C	530307305
RLAY	RELAY THERAPEUTICS INC	1,317,870	$14.51M	4.6%	$14.33	-41.1%	COM	75943R102
—	MORPHIC HOLDING INC	496,856	$14.35M	4.5%	$44.89	—	COM	61775R105
SRPT	SAREPTA THERAPEUTICS INC	145,357	$14.02M	4.4%	$115.73	-17.1%	COM	803607100
TVTX	TRAVERE THERAPEUTICS INC	1,435,321	$12.9M	4.1%	$17.56	-58.5%	COM	89422G107
PRTA	PROTHENA CORP PLC	349,300	$12.69M	4.0%	$33.98	+13.3%	SHS	G72800108
SLDB	SOLID BIOSCIENCES INC	961,251	$5.902M	1.9%	$5.95	-46.2%	COM NEW	83422E204
—	CALIDI BIOTHERAPEUTICS INC	125,000	$189K	0.1%	$3.33	—	COM NEW	320703101
—	CHURCHILL CAPITAL CORP VII	548,000	$71,295	0.0%	$0.92	—	*W EXP 02/29/202	17144M110
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	895,000	$62,740	0.0%	$43.35	+18.9%	CLASS A ORD	61559X104
CNDAW	CONCORD ACQUISITION CORP II	408,333	$53,083	0.0%	$0.95	—	*W EXP 99/99/999	20607U116
CLDWW	CALIDI BIOTHERAPEUTICS INC	655,200	$32,760	0.0%	$0.50	—	*W EXP 03/14/202	320703119
—	ROSS ACQUISITION CORP II	439,666	$24,621	0.0%	$0.89	—	*W EXP 02/01/202	G7641C114
CDAWF	COMPASS DIGITAL ACQUISITION CORP	459,906	$22,259	0.0%	$0.76	—	*W EXP 09/29/202	G2476C123
—	MARBLEGATE ACQUISITION CORP	735,000	$22,050	0.0%	$0.50	—	*W EXP 08/31/202	56608A113
IVCPW	SWIFTMERGE ACQUISITION CORP	490,000	$20,090	0.0%	$0.21	—	*W EXP 12/13/202	G63836111
LSBWF	YS BIOPHARMA CO LTD	489,999	$13,279	0.0%	$0.16	—	*W EXP 03/15/202	G9845F117